Genetic Testing Market Outlook, Analysis, Region & Country Revenue Share, & Forecast Till 2030

 


The Genetic Testing market size was valued USD 15.3 billion in 2021 and projected to reach USD 33.4 billion by 2030 at CAGR of 10.5% during the forecast period 2022-2030. As per Global Market analysts, the global market is anticipated to witness growth owing to the factors such as the rising prevalence of genetic disorders as well as the rising awareness about the benefits of genetic testing. However, the Global Market will face challenges and restraints due to lack of expertise and the lack of medical solutions for all the diseases diagnosed during the forecast period 2022 to 2030.

The increasing prevalence of genetic disorders in the Global Market is set to play a key role in determining the growth potential during 2022 to 2030 years. Analysts have also studied the Global Market to understand potential threats and challenges the Global Market companies could face. Although the Global Market is poised to grow at a fast pace across method, applications, and type segments, factors such as the shortage of trained technicians could slow down the Global market's growth worldwide.

Market Segmentation

The Global Genetic Testing Market outlook has been segmented into method, applications, and type. Based on the segment which is method, the market is categorized on the basis of biochemical genetic tests, chromosomal genetic tests, and molecular genetic tests/DNA tests. The global market for genetic testing is further segmented based on applications into reproductive health (carrier screening, newborn screening, and prenatal screening), cancer screening (breast cancer, colon cancer, hereditary cancer, and ovarian cancer), ancestry, pre-symptomatic testing, predictive, and others. Furthermore, the market, on the basis of type is segmented into prescribed genetic testing and direct-to-consumer genetic testing.

The global Market research report covers all the aspects of the Global Market based on the segmental analysis of these method, applications, and type segments. Analysts have also studied the global genetic testing market's regional markets spread across many continents and countries. The method, applications, and type segments along with their sub-segments have been analyzed and companies functioning in the Global Market across these segments are profiled and analyzed based on input and feedback from Global Market based decision makers as well as primary and secondary sources. The Global Market research report presents analysis based information for companies functioning in the genetic testing market.

Regional Overview

The lack of solutions for all the diseases diagnosed may hinder the Global Market growth. The market research report suggests that companies in the Global Market could be supported by the increasing need to find a cure to cancer as well as demand for effective testing during the forecast period. The Global Market is set to register growth at a high CAGR owing to these key factors. The Genetic Testing Market is spread across North America, Europe, Asia-Pacific, and other parts of the world. The global Genetic Testing Market research report reveals that APAC, North America, and Europe regional genetic testing markets will dominate the global market for genetic testing during the forecast period 2019 to 2024. As per Global Market analysts, the market is set to witness tremendous growth across molecular genetic test/DNA test and reproductive health segments in North America which covers Global markets across the United States, Canada, Mexico and several other regional markets. Companies active in the Global Market are also analyzed and studied in the Global Market research report.

The Global Market for Europe covers smaller market segments of Germany, Italy, France, and the United Kingdom. Additionally, the Global Market research report covers the Asia-Pacific region covering genetic testing markets from India, China, Japan, Australia, and others. The Global Market is also spread across the rest of the world. The Global Market report covers all such regions including the Middle East, Africa, Brazil, and others.

Key Players

Cardiac Genetic Testing companies include BGI Genomics (China), Thermo Fisher Scientific Inc. (US), Blueprint Genetics (Finland), F. Hoffmann-La Roche Ltd (Switzerland), Eurofins Scientific (US), Quest Diagnostics Incorporated (US), Illumina Inc. (US), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), PerkinElmer Inc. (US), and Myriad Genetics, Inc. (US). 

Access Report @ https://www.marketresearchfuture.com/reports/genetic-testing-market-2009

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Doxorubicin Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
Doxorubicin is a type of chemotherapy medicine called an anthracycline. It is used to reduce or diminish the growth of cancer cells by blocking an enzyme called topo isomerase. Factors that are propelling the growth of the  doxorubicin market  are surge in geriatric population, rising prevalence of different types of cancer, increasing awareness for cancer treatment. According to the International Federation of Pharmaceutical Manufacturers & Associations, global pharmaceutical industry has spent more than USD 149.8 billion on pharmaceutical Research and development activities. The various side effects, cost containment policies by various governments, stringent regulatory environment for product approval, are likely to hinder market growth during the forecast period. Regional Analysis The American market is expected to dominate the global doxorubicin market during the forecast period due to the presence of major manufacturers, increase in number of cancer cases, awareness ...
Read more

Chromatography Software Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
According to MRFR analysis, the global  Chromatography Software Market  is expected to register a CAGR of ~8.1% from 2022 to 2030 and hold a value of USD 15,330 million by 2030. Chromatography software is the gadget that allows chromatography-based analysis. This software system organizes and manages data from chromatography instruments, records and processes it, and generates chromatograms and reports. Data processing, instrument control, and database management are automated using this chromatography data software. Chromatography informatics solutions are available in various formats, from integrated to automated independent software platforms. These tools are employed in multiple sectors, including materials science, drug development, and forensics. The growing demand for chromatography applications in different fields, surge in the utilization of chromatography techniques in R&D activities across various industries such as the pharmaceutical industry and increasing tec...
Read more

Orthokeratology Lens Market Revenue Trends, Company Profiles, Revenue Share Analysis Till 2030

Image
The   Orthokeratology Lens Market   is expected to reach USD 3,900.8 Million by 2030 at 7.8% CAGR during the forecast period 2022-2030. Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. In the orthokeratology therapy, rigid gas permeable contact lenses are worn overnight that reshapes the curvature of the cornea to improve object visibility. The use of ortho-k lenses eliminates the need for daytime contact lenses or glasses and improves vision. The increasing advancements in the field of ophthalmology over the past couple of decades, low cost compared to laser-assisted in situ keratomileuses (LASIK) treatment is anticipated to drive the market growth. However, the risk associated with orthokeratology and availability of alternative treatment methods is likely to hamper the market growth. Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/8218 Segment Analysis The global ortho...
Read more